Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-11-18
2009-02-03
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S416000, C544S235000, C548S361500
Reexamination Certificate
active
07485643
ABSTRACT:
Disclosed are compounds of the Formula Iand pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8, R9, R10, R20, R21, and R22are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.
REFERENCES:
patent: 5231094 (1993-07-01), Bru-Magniez et al.
patent: 5525625 (1996-06-01), Bridges et al.
patent: 6310060 (2001-10-01), Barrett et al.
patent: 6469004 (2002-10-01), Barrett et al.
patent: 6506798 (2003-01-01), Barrett et al.
patent: 2003/0004193 (2003-01-01), Barrett et al.
patent: 2003/0045521 (2003-03-01), Tecle
patent: 2003/0078428 (2003-04-01), Barrett et al.
patent: 2003/0092748 (2003-05-01), Barrett et al.
patent: 2003/0195183 (2003-10-01), Zhilov
patent: 2003/0216460 (2003-11-01), Wallace et al.
patent: 2003/0232869 (2003-12-01), Wallace et al.
patent: 2004/0116710 (2004-06-01), Wallace et al.
patent: WO 95/03286 (1995-02-01), None
patent: WO 98/43960 (1998-10-01), None
patent: WO 99/01421 (1999-01-01), None
patent: WO 99/01426 (1999-01-01), None
patent: WO 00/40235 (2000-07-01), None
patent: WO 00/40237 (2000-07-01), None
patent: WO 00/41505 (2000-07-01), None
patent: WO 00/41994 (2000-07-01), None
patent: WO 00/42002 (2000-07-01), None
patent: WO 00/42003 (2000-07-01), None
patent: WO 00/42022 (2000-07-01), None
patent: WO 00/42029 (2000-07-01), None
patent: WO 00/68201 (2000-11-01), None
patent: WO 01/05390 (2001-01-01), None
patent: WO 01/05391 (2001-01-01), None
patent: WO 01/05392 (2001-01-01), None
patent: WO 01/05393 (2001-01-01), None
patent: WO 01/68619 (2001-09-01), None
patent: WO 02/06213 (2002-01-01), None
patent: WO 02/18319 (2002-03-01), None
patent: WO 02/44166 (2002-06-01), None
patent: WO 03/077855 (2003-09-01), None
patent: WO 03/077914 (2003-09-01), None
patent: PCT/US2004/039059 (2004-11-01), None
M-C Viaud, et al. “Acylation of Oxazolo[4,5-b]Pyridin-2(3H)-Ones, 2-Phenyloxazolo[4,5-b]Pyridines and Pyrrolo[2,3-b]Pyridin-2(2H)-Ones”; Tetrahedron; 1997; pp. 5159-5168; vol. 53, No. 14; Elsevier Science Ltd.; Great Britain.
Moreau, et al. “Synthesis and Anticonvulsant Properties of Triazolo- and Imidazopyridazinyl Carboxamides and Carboxylic Acids” Bioorganic & Medicinal Chemistry; 1998; pp. 983-991; vol. 6; Elsevier Science Ltd.
Bachman “Further Studies of Aminobenzacridines”; Journal of Organic Chemistry; 1948; pp. 89-96; vol. 13.
Lyssikatos Joseph P.
Wallace Eli
Yang Hong Woon
Array BioPharma Inc.
Hogan & Hartson LLP
Moore John R.
Sackey Ebenezer
Wilson James O.
LandOfFree
Bicyclic inhibitors of MEK and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic inhibitors of MEK and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic inhibitors of MEK and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4073623